RIPE-KG · Version 1.1.0 · Resource

ripekg:evaluation/RIPEA3A616563C128D80E

https://w3id.org/ripe/ripe-kg/evaluation/RIPEA3A616563C128D80E
SubjectPredicateObject
ripekg:evaluation/RIPEA3A616563C128D80E rdf:type rdfs:Resource
ripekg:evaluation/RIPEA3A616563C128D80E rdf:type owl:Thing
ripekg:evaluation/RIPEA3A616563C128D80E rdf:type tido:Evaluation
ripekg:evaluation/RIPEA3A616563C128D80E prov:endedAtTime 2026-04-05T16:01:35.617350Z
ripekg:evaluation/RIPEA3A616563C128D80E prov:startedAtTime 2026-04-05T15:49:58.526068Z
ripekg:evaluation/RIPEA3A616563C128D80E prov:used ripekg:publication-details/RIPEA3A616563C128D80EHesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial
ripekg:evaluation/RIPEA3A616563C128D80E prov:used ripekg:registry-evidence/RIPEA3A616563C128D80E
ripekg:evaluation/RIPEA3A616563C128D80E prov:used ripekg:retraction-notice/22386Bioinformatic Analysis of Codon Usage and Phylogenetic Relationships in Different Genotypes of the Hepatitis C Virus
ripekg:evaluation/RIPEA3A616563C128D80E prov:used ripekg:retraction-notice/22387Bioinformatic Analysis of Codon Usage and Phylogenetic Relationships in Different Genotypes of the Hepatitis C Virus
ripekg:evaluation/RIPEA3A616563C128D80E prov:used ripekg:study-design-evidence/RIPEA3A616563C128D80E
ripekg:evaluation/RIPEA3A616563C128D80E prov:wasAssociatedWith ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0
ripekg:evaluation/RIPEA3A616563C128D80E prov:wasAssociatedWith ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI
ripekg:evaluation/RIPEA3A616563C128D80E prov:wasAssociatedWith ripekg:human-reviewer/RV015
ripekg:evaluation/RIPEA3A616563C128D80E prov:wasInformedBy ripekg:evidence-aggregation/RIPEA3A616563C128D80E
ripekg:evaluation/RIPEA3A616563C128D80E tido:contributesTo ripekg:research-integrity-assessment/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-human-1-1 prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-human-1-2 prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-human-1-3 prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-human-2-2 prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-human-overall prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-inspectai-1-1 prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-inspectai-1-2 prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-inspectai-1-3 prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-inspectai-2-2 prov:wasGeneratedBy ripekg:evaluation/RIPEA3A616563C128D80E